 |
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2025, vol. 31, issue2
Subject Area: Medicine
-
DOI: 10.5272/jimab.2025312.6111
Published online: 02 April 2025
Review article
J of IMAB. 2025 Apr-Jun;31(2):6111-6115
ASPECTS OF INSULIN RESISTANCE IN CHILDREN WITH AUTISM
Rozalina Braykova
, Albena Toneva,
Department of Hygiene and Epidemiology, Faculty of Public Health, Medical University Varna, Bulgaria.
ABSTRACT:
Purpose: To investigate aspects of insulin resistance in children with autism.
Material/Methods: In January 2024, the search was conducted using three bibliographic databases: PubMed, Scopus, Google Scholar, and Mendeley. The objective of the search was to find relevant sources on metabolic diseases Insulin resistance (IR) in Autism spectrum disorders (ASD) from 2016 to 2023. The search technique involved using the terms and keywords: "(IR OR Insulinopathie) AND (child OR toddler OR adolescent OR school age) AND (ASD OR Autism)." The two independent reviewers (RB and AT) systematically conducted the data extraction process.
Results: There is no conclusive evidence that prenatal insulin resistance is a risk factor for the onset of autism. Poor eating habits, lack of physical activity, presence of other medical conditions, and use of medications can contribute to increased obesity rates in children with ASD, leading to potential health issues like diabetes, insulin problems, and heart disease. Some experts highlight the metabolic risks, specifically insulin resistance, associated with prescribing antipsychotic drugs to children with autism. Risperidone causes a notable increase in weight and serum triglyceride levels, even when used briefly. Teenagers with autism spectrum disorder demonstrate increased HOMA-IR levels, possibly indicating decreased glucose utilization in certain areas of the brain.
Conclusion: Understanding how insulin resistance affects peripheral metabolism and the CNS could lead to extensive research to enhance the neuropsychological development of children with autism and have implications for public health.
Keywords: IR, Insulinopathie, ASD, child,
- Download FULL TEXT /PDF 492 KB/
Please cite this article as: Braykova R, Toneva A. Aspects of Insulin Resistance in Children with Autism. J of IMAB. 2025 Apr-Jun;31(2):6111-6115. [Crossref - 10.5272/jimab.2025312.6111]
Correspondence to: Rozalina Braykova, Department of Hygiene and Epidemiology, Faculty of Public Health, Medical University – Varna; 1, Zahari Stoyanov Str., 9300 Dobrich, Bulgaria; E-mail: rozalina.braykova@mu-varna.bg
REFERENCES:
1. Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J. Autism spectrum disorder. Lancet. 2018 Aug 11;392(10146):508–520. [PubMed]
2. Alhowikan AM, AL-Ayadhi LY, Halepoto DM. Impact of environmental pollution, dietary factors, and diabetes mellitus on Autism Spectrum Disorder (ASD). Pak J Med Sci. 2019 Jul-Aug;35(4):1179-1184. [PubMed]
3. Gadad BC, Hewitson L, Young KA, German DC. Neuropathology and Animal Models of Autism: Genetic and Environmental Factors. Autism Res Treat. 2013;2013:731935. [PubMed]
4. Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018 February;20(2). [PubMed]
5. Rivell A, Mattson M. Intergenerational Metabolic Syndrome and Neuronal Network Hyperexcitability in Autism. Trends Neurosci. 2019 Oct;42(10):709-726. [PubMed]
6. Yadav A, Kataria M, Saini V, Yadav A. Role of leptin and adiponectin in insulin resistance. Clin Chim Acta. 2013 Feb 18;417:80–4. [PubMed]
7. Dhaliwal K, Avedzi H, Richard C, Zwaigenbaum L, Haqq A. Brief Report: Plasma Leptin and Mealtime Feeding Behaviors Among Children with Autism Spectrum Disorder: A Pilot Study. J Autism Dev Disord. 2023 Dec;53(12):4929-4936. [PubMed]
8. Dhaliwal K, Orsso C, Richard C, Haqq A, Zwaigenbaum L. Risk Factors for Unhealthy Weight Gain and Obesity among Children with Autism Spectrum Disorder. Int J Mol Sci. 2019 Jul 4;20(13):3285. [PubMed]
9. Sukasem C, Vanwong N, Srisawasdi P, et al. Pharmacogenetics of risperidone-induced insulin resistance in children and adolescents with autism spectrum disorder. Basic Clin Pharmacol Toxicol. 2018 Jul;123(1):42-50. [PubMed]
10. Hervas A, Serra-LLovich A, Rueda I, Targa, I, Guijarro S, Bigorra A, et al. Pharmacogenetic influences on the response to pharmacological treatment in autism spectrum disorders. J Transl Genet Genom. 2021; 5:278-87. [Crossref]
11. Cortese S, Gabellone A, Marzulli L, Iturmendi-Sabater I, de La Chica-Duarte D, Piqué I, et al. Association between autism spectrum disorder and diabetes: systematic review and meta-analysis. Neurosci Biobehav Rev. 2022 May;136:104592. [PubMed]
12.Sullivan M, Fernandez-Aranda F, Camacho-Barcia L, Harkin A, Macrì S, Mora-Maltas B, et al. Insulin and disorders of behavioral flexibility. Neurosci Biobehav Rev. 2023 Jul;150:105169. [PubMed]
13. Mukhtarova K, Kanderzhanova A, Issanov A, Chan CK. Genetic Variations Influencing Glucose Homeostasis and Insulin Secretion and their Associations with Autism Spectrum Disorder in Kazakhstan. Electron J Gen Med. 2021 Apr;18(2):274. [Crossref]
14. Rivell A, Mattson M. Intergenerational Metabolic Syndrome and Neuronal Network Hyperexcitability in Autism. Trends Neurosci. 2019 Oct;42(10):709-726. [PubMed]
15. Sullivan E, Nousen E, Chamlou K, Grove K. The Impact of Maternal High-Fat Diet Consumption on Neural Development and Behavior of Offspring. Int J Obes Suppl. 2012; 2(Suppl.2):S7-S13. [PubMed]
16. Myers-Morrison C. Parental Obesity: The Pandemic of Intergenerational Physical and Mental Health Carnage. Int J Integr Pediatr Environ Med. 2023 Mar;8:1-19. [Crossref]
17. Catalano P, Shankar K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child. BMJ. 2017 Feb 8;356:j1. [PubMed]
18. Bellver J, Mariani G. Impact of parental over- and underweight on the health of offspring. Fertil Steril. 2019 Jun;111(6):1054-1064. [PubMed]
19. Flores-Dorantes M, Díaz-López Y, Gutiérrez-Aguilar R. Environment and Gene Association With Obesity and Their Impact on Neurodegenerative and Neurodevelopmental Diseases. Front Neurosci. 2020 Aug 28;14:863. [PubMed]
20. Sertie R, Kang M, Antipenko J, Liu X, Maianu L, Habegger K, et al. In utero nutritional stress as a cause of obesity: Altered relationship between body fat, leptin levels, and caloric intake in offspring into adulthood. Life Sci. 2020 Aug 1;254:117764. [PubMed]
21.Shannon K. Risk Factors for Obesity and Unhealthy Weight Gain in Autism Spectrum Disorder Children. J Pediatr Neurol Disord. 2023; 6(3):63-66.
22. García O, Long K, Rosado J. Impact of micronutrient deficiencies on obesity. Nutr Rev. 2009 Oct;67(10):559-72. [PubMed]
23. Manco M, Guerrera S, Ravà L, Ciofi Degli Atti M, Di Vara S, Valeri G, et al. Cross-sectional investigation of insulin resistance in youths with autism spectrum disorder. Any role for reduced brain glucose metabolism? Transl Psychiatry. 2021 Apr 20;11(1):229. [PubMed]
24. Alavi A, Reivich M. Guest editorial: the conception of FDG-PET imaging. Semin Nucl Med. 2002 Jan;32(1):2-5. [PubMed]
25. Luçardo JDC, Monk GF, Dias MDS, Martins-Silva T, Fernandes MP, Maia JC, et al. Interest in food and triglyceride concentrations in children and adolescents with autistic spectrum disorder. J Pediatr (Rio J) 2021 Jan-Feb;97(1):103-108. [PubMed]
26. Tromans S, Yao G, Alexander R, Mukaetova-Ladinska E, Kiani R, Al-Uzri M, et al. The Prevalence of Diabetes in Autistic Persons: A Systematic Review. Clin Pract Epidemiol Ment Health. 2020 Dec;16: 212–225. [PubMed]
27. Scahill L, Jeon S, Boorin S, McDougle C, Aman M, Dziura J, et al. Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder. J Am Acad Child Adolesc Psychiatry. 2016 May;55(5):415-23. [PubMed]
28. Libowitz MR, Nurmi EL. The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children. Front Psychiatry. 2021 Mar 12;12:623681. [PubMed]
Received: 06 November 2024
Published online: 02 April 2025